Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | PREP | P48147 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31612525 | 0.81 | ABCB11 (0.42) | ABCB11MEN1KMT2ABACE1ALDH1A1 | |
| SCHEMBL13814014 | 0.81 | ABCB11 (0.42) | ABCB11MEN1KMT2ABACE1ALDH1A1 | |
| SCHEMBL31612522 | 0.81 | ABCB11 (0.44) | ABCB11MEN1KMT2ABACE1ALDH1A1 | |
| SCHEMBL8666830 | 0.76 | ABCB11 (0.50) | ABCB11MEN1KMT2ABACE1ALDH1A1 | |
| SCHEMBL4645395 | 0.72 | ABCB11 (0.49) | ABCB11MEN1KMT2ABACE1ALDH1A1 | |
| SCHEMBL11245676 | 0.71 | ABCB11 (0.41) | ABCB11MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL31006515 | 0.71 | KMT2A (0.46) | ABCB11MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL5688964 | 0.71 | LMNA (0.43) | ABCB11MEN1KMT2ABACE1ALDH1A1 | |
| SCHEMBL8928647 | 0.70 | MAPK1 (0.43) | ABCB11MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL4641540 | 0.69 | POLB (0.43) | ABCB11MEN1KMT2ABACE1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638748-A2 | COMPOSITIONS AND METHODS FOR PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) EDITING | Intellia Therapeutics, Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| WO-2025038642-A1 | COMPOSITIONS AND METHODS FOR GENETICALLY MODIFYING CD70 | INTELLIA THERAPEUTICS, INC. (US) | 2025-02-20 | — | — | WO | claimed |
| EP-4426338-A2 | CD38 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | Intellia Therapeutics, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| EP-4392060-A1 | PROGRAMMED CELL DEATH PROTEIN 1 (PD1) COMPOSITIONS AND METHODS FOR CELL-BASED THERAPY | Intellia Therapeutics, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| WO-2024137766-A2 | COMPOSITIONS AND METHODS FOR PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) EDITING | INTELLIA THERAPEUTICS, INC. (US) | 2024-06-27 | — | — | WO | claimed |
| EP-4352225-A1 | MODIFIED GUIDE RNAS COMPRISING AN INTERNAL LINKER FOR GENE EDITING | Intellia Therapeutics, Inc. (US) | 2024-04-17 | — | — | EP | claimed |
| EP-4288088-A2 | LYMPHOCYTE ACTIVATION GENE 3 (LAG3) COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | Intellia Therapeutics, Inc. (US) | 2023-12-13 | — | — | EP | claimed |
| EP-4288089-A2 | T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3 (TIM3) COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | Intellia Therapeutics, Inc. (US) | 2023-12-13 | — | — | EP | claimed |
| EP-4288525-A1 | NATURAL KILLER CELL RECEPTOR 2B4 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | Intellia Therapeutics, Inc. (US) | 2023-12-13 | — | — | EP | claimed |
| CN-116849291-B | Fermented feed for enhancing animal immunity and preparation method thereof | 广东海洋大学 | 2023-12-08 | — | — | CN | claimed |
| CN-116849291-A | Fermented feed for enhancing animal immunity and preparation method thereof | 广东海洋大学 | 2023-10-10 | — | — | CN | claimed |
| EP-3637235-B1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2023-08-30 | — | — | EP | claimed |
| CN-116590373-A | Fermented lactobacillus mucilaginosus extracellular polysaccharide, preparation method and application | 广东海洋大学 | 2023-08-15 | — | — | CN | claimed |
| WO-2023081200-A2 | CD38 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | INTELLIA THERAPEUTICS, INC. (US) | 2023-05-11 | — | — | WO | claimed |
| WO-2023028471-A1 | PROGRAMMED CELL DEATH PROTEIN 1 (PD1) COMPOSITIONS AND METHODS FOR CELL-BASED THERAPY | INTELLIA THERAPEUTICS, INC. (US) | 2023-03-02 | — | — | WO | claimed |
| WO-2022261292-A1 | MODIFIED GUIDE RNAS COMPRISING AN INTERNAL LINKER FOR GENE EDITING | INTELLIA THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | claimed |
| EP-4073249-A1 | MODIFIED GUIDE RNAS FOR GENE EDITING | Intellia Therapeutics, Inc. (US) | 2022-10-19 | — | — | EP | claimed |
| WO-2022170172-A1 | NATURAL KILLER CELL RECEPTOR 2B4 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | INTELLIA THERAPEUTICS, INC. (US) | 2022-08-11 | — | — | WO | claimed |
| WO-2022170193-A2 | T-CELL IMMUNOGLOBULIN AND MUCIN DOMAIN 3 (TIM3) COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | INTELLIA THERAPEUTICS, INC. (US) | 2022-08-11 | — | — | WO | claimed |
| WO-2022170194-A2 | LYMPHOCYTE ACTIVATION GENE 3 (LAG3) COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | INTELLIA THERAPEUTICS, INC. (US) | 2022-08-11 | — | — | WO | claimed |